Filing
Spy
Filing
Spy
Home
About
GILD
Gilead Sciences, Inc.
Biopharmaceutical company
CUSIP: 375558103
Healthcare
US
4 holders
Ownership
Activity
Fundamentals
2021 Q1
20 of 52 quarters
Total Value
$809.54M
Total Shares
12.53M
Net Share Change
+1.19M
Activity
4 buying
Investor
Value
Shares
Weight
Change
Dodge & Cox Stock Fund
$782.23M
12.10M
1.0%
ADD
+1.12M
(+10.2%)
Dodge & Cox Stock Fund
$782.23M
12.10M shares
ADD
+1.12M
(+10.2%)
GILD — Gilead Sciences, Inc. - FilingSpy
Matrix Asset Advisors
$22.67M
350.7K
3.4%
ADD
+50.4K
(+16.8%)
Matrix Asset Advisors
$22.67M
350.7K shares
ADD
+50.4K
(+16.8%)
Bridgewater Associates LP
$3.98M
61.6K
0.0%
ADD
+11.0K
(+21.7%)
Bridgewater Associates LP
$3.98M
61.6K shares
ADD
+11.0K
(+21.7%)
Pzena Investment Management
$666.0K
10.3K
0.0%
ADD
+232
(+2.3%)
Pzena Investment Management
$666.0K
10.3K shares
ADD
+232
(+2.3%)